Financial results - JUSTIN PHARMA SRL

Financial Summary - Justin Pharma Srl
Unique identification code: 37916598
Registration number: J2017001063329
Nace: 1086
Sales - Ron
215.356
Net Profit - Ron
57.384
Employees
1
Open Account
Company Justin Pharma Srl with Fiscal Code 37916598 recorded a turnover of 2024 of 215.356, with a net profit of 57.384 and having an average number of employees of 1. The company operates in the field of Fabricarea preparatelor alimentare omogenizate şi alimentelor dietetice having the NACE code 1086.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Justin Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 18.370 44.330 46.352 78.475 86.457 91.422 155.632 215.356
Total Income - EUR - - 18.370 44.972 46.746 80.046 86.571 91.822 156.532 216.105
Total Expenses - EUR - - 11.072 38.103 42.630 65.783 46.469 101.931 116.839 149.818
Gross Profit/Loss - EUR - - 7.298 6.869 4.116 14.262 40.102 -10.110 39.693 66.287
Net Profit/Loss - EUR - - 6.131 6.350 3.679 13.438 39.220 -11.030 38.128 57.384
Employees - - 1 0 0 0 0 1 0 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 39.2%, from 155.632 euro in the year 2023, to 215.356 euro in 2024. The Net Profit increased by 19.469 euro, from 38.128 euro in 2023, to 57.384 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Justin Pharma Srl

Rating financiar

Financial Rating -
JUSTIN PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Justin Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Justin Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Justin Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Justin Pharma Srl - CUI 37916598

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 149 5.643 4.799 11.781 10.096 8.496 6.844 38.480
Current Assets - - 18.534 20.364 46.215 88.077 125.281 100.235 150.613 288.881
Inventories - - 0 2.240 5.116 53.669 85.593 53.595 62.357 163.514
Receivables - - 18.370 16.695 37.283 33.483 35.772 41.126 81.611 124.550
Cash - - 164 1.429 3.817 926 3.916 5.514 6.645 817
Shareholders Funds - - 6.131 12.411 15.849 28.987 67.564 56.744 94.700 243.333
Social Capital - - 0 43 42 41 40 41 40 40
Debts - - 12.552 13.596 35.165 70.871 67.812 51.987 62.757 84.302
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "1086 - 1086"
CAEN Financial Year 1086
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 288.881 euro in 2024 which includes Inventories of 163.514 euro, Receivables of 124.550 euro and cash availability of 817 euro.
The company's Equity was valued at 243.333 euro, while total Liabilities amounted to 84.302 euro. Equity increased by 149.162 euro, from 94.700 euro in 2023, to 243.333 in 2024.

Risk Reports Prices

Reviews - Justin Pharma Srl

Comments - Justin Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.